Biological Products, (No Diagnostic Substances)
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| EQT Fund Management S.a r.l. | 5.14M | $66.0M | -- | -- | 2026-06-30 |
| Sanofi | 2.78M | $36.0M | -- | -- | 2026-06-30 |
| Redmile Group, LLC | 2.73M | $35.0M | -- | +2.58M | 2026-06-30 |
| Cormorant Asset Management, LP | 2.47M | $32.0M | -- | -- | 2026-06-30 |
| TCG Crossover Management, LLC | 2.05M | $26.0M | -- | -- | 2026-06-30 |
| FEDERATED HERMES, INC. | 1.62M | $21.0M | -- | -- | 2026-06-30 |
| Nantahala Capital Management, LLC | 1.57M | $20.0M | -- | +368.2K | 2026-06-30 |
| Casdin Capital, LLC | 1.55M | $20.0M | -- | -- | 2026-06-30 |
| ANDERA PARTNERS | 1.54M | $19.0M | -- | -- | 2026-06-30 |
| FMR LLC | 1.46M | $18.0M | -- | -- | 2026-06-30 |
